Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knud Kragballe

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Ugeskrift for Laeger|October 28, 2005
[Quality and documentation prior to dermatological laser treatment]Knud Kragballe
The British Journal of Dermatology|March 21, 2007
Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in DenmarkKnud Kragballe
Current Problems in Dermatology|August 28, 2009
Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nailsKnud Kragballe
Cutis|December 7, 2002
Vitamin D and UVB radiation therapyKnud Kragballe
Current Drug Targets. Inflammation and Allergy|June 8, 2004
New vitamin D analogs in psoriasisKarsten Fogh, Knud Kragballe
Cutis|March 21, 2007
An innovation in topical therapy: insights from international dermatologistsKnud Kragballe, Linda Corvari
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of psoriasis and psoriatic arthritis]Knud Kragballe, Bent Deleuran
Ugeskrift for Laeger|March 31, 2007
[Biological dermatologic agents. The Danish Society of Dermatology]Lars Iversen, Knud Kragballe,
International Journal of Dermatology|August 17, 2006
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointmentAlex V Anstey, Knud Kragballe
Archives of Dermatological Research|August 16, 2003
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiationClaus Johansen, Knud Kragballe, Lars Iversen
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Ugeskrift for Laeger|October 28, 2005
[Quality and documentation prior to dermatological laser treatment]Knud Kragballe
The British Journal of Dermatology|March 21, 2007
Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in DenmarkKnud Kragballe
Current Problems in Dermatology|August 28, 2009
Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nailsKnud Kragballe
Cutis|December 7, 2002
Vitamin D and UVB radiation therapyKnud Kragballe
Current Drug Targets. Inflammation and Allergy|June 8, 2004
New vitamin D analogs in psoriasisKarsten Fogh, Knud Kragballe
Cutis|March 21, 2007
An innovation in topical therapy: insights from international dermatologistsKnud Kragballe, Linda Corvari
Ugeskrift for Laeger|June 21, 2008
[Biological treatment of psoriasis and psoriatic arthritis]Knud Kragballe, Bent Deleuran
Ugeskrift for Laeger|March 31, 2007
[Biological dermatologic agents. The Danish Society of Dermatology]Lars Iversen, Knud Kragballe,
International Journal of Dermatology|August 17, 2006
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointmentAlex V Anstey, Knud Kragballe
Archives of Dermatological Research|August 16, 2003
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiationClaus Johansen, Knud Kragballe, Lars Iversen
Pageof 6